MUMSS
EW icon

Mitsubishi UFJ Morgan Stanley Securities’s Edwards Lifesciences EW Stock Holding History

Mitsubishi UFJ Morgan Stanley Securities’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-40
Closed -$3K – 82
2022
Q4 		$3K Sell
40
-40
-50% -$3.08K 0.03% 167
2022
Q3 		$7K Hold
80
– – 0.09% 123
2022
Q2 		$8K Hold
80
– – 0.01% 122
2022
Q1 		$9K Sell
80
-270
-77% -$30.3K 0.01% 119
2021
Q4 		$45K Sell
350
-350
-50% -$40.8K 0.02% 93
2021
Q3 		$79K Buy
+700
New +$79.9K 0.07% 44

Other funds holding EW

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Mitsubishi UFJ Morgan Stanley Securities's EW Position: Q1 2023 in Review

Mitsubishi UFJ Morgan Stanley Securities sold out of Edwards Lifesciences (EW) in Q1 2023, closing a stake of 40 shares — an estimated $3K sold.

Mitsubishi UFJ Morgan Stanley Securities first reported a position in EW in Q3 2021 and held it in 6 quarters. The position peaked at $79K in Q3 2021. 1,245 funds tracked by Wall St. Rank hold EW as of Q1 2023.

  • Mitsubishi UFJ Morgan Stanley Securities reported no remaining Edwards Lifesciences position as of Q1 2023 after selling out during the quarter.
  • Mitsubishi UFJ Morgan Stanley Securities sold 40 Edwards Lifesciences shares in Q1 2023, an estimated $3K.
  • Mitsubishi UFJ Morgan Stanley Securities first reported a position in Edwards Lifesciences in Q3 2021 and held it in 6 quarters.
  • Mitsubishi UFJ Morgan Stanley Securities's Edwards Lifesciences position peaked at $79K in Q3 2021.
  • 1,245 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2023.

Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q1 2023, filed 2 May 2023.